Purdue Pharma’s Sacklers Increase Opioid Settlement Offer to $4.3B: Reuters
Members of the Sackler family who own Purdue Pharma LP have offered roughly $4.3 billion to resolve sprawling opioid litigation, up from $3 billion initially proposed in settlement discussions underway in the OxyContin maker’s bankruptcy proceedings, four people familiar with …